Treace Medical Concepts, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Treace Medical Concepts, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-12-31 was 1.39M shares.
- Treace Medical Concepts, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-09-30 was 16.98K shares.
- Treace Medical Concepts, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-06-30 was 272.08K shares.
- Treace Medical Concepts, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-03-31 was 690.55K shares.
- Treace Medical Concepts, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 356.45K shares, a 21.98% increase from fiscal 2024.
- Treace Medical Concepts, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 292.22K shares, a 41.01% decline from fiscal 2023.
- Treace Medical Concepts, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 495.34K shares, a 65.71% decline from fiscal 2022.
- Treace Medical Concepts, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 1.44M shares, a 39.01% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 356.45K shares 10-K · filed 2026-02-27 | |
| 2024-12-31 | 292.22K shares 10-K · filed 2025-02-27 | |
| 2023-12-31 | 495.34K shares 10-K · filed 2024-02-27 | |
| 2022-12-31 | 1.44M shares 10-K · filed 2023-03-08 | |
| 2021-12-31 | 1.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | 2.37M shares 10-K · filed 2022-03-04 |
| 2021-09-30 | 16.98K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | |
| 2021-06-30 | 272.08K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | |
| 2021-03-31 | 690.55K shares 10-Q · filed 2021-05-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |